Peng Kevin A, Kuan Edward C, Unger Lindsey, Lorentz William C, Wang Marilene B, Long Jennifer L
Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA
Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Otolaryngol Head Neck Surg. 2015 May;152(5):863-7. doi: 10.1177/0194599815575508. Epub 2015 Mar 31.
Determine the efficacy of a swallow preservation protocol (SPP) on maintaining swallow function in patients undergoing chemoradiation (CRT) or radiation therapy alone (RT) for head and neck squamous cell carcinoma (HNSCC).
Retrospective case series.
Veterans Affairs medical center.
Patients treated with CRT or RT for HNSCC between February 2006 and November 2013 were studied. Those enrolled in the SPP participated in swallowing, jaw, and tongue exercises during cancer therapy. The comparator group received no swallowing intervention during CRT. A previously described functional outcome swallowing scale (FOSS; 0 = no symptoms and 5 = nonoral feeding for all nutrition) was used to quantify dysphagia prior to and at the completion of cancer therapy, and an analysis was performed to compare swallowing function.
Forty-one (all male; mean age, 66 years) and 66 patients (all male; mean age, 61 years) were included in the SPP and comparator groups, respectively. In the SPP group, mean pre- and posttreatment FOSS scores were 2.2 and 2.2, respectively, while the corresponding scores in the comparator group were 1.8 and 2.7, respectively, with posttreatment FOSS scores being significantly worse than pretreatment FOSS scores in the comparator group only.
Patients enrolled in the SPP demonstrated preserved swallowing function over the course of cancer treatment compared with a comparator group. This confirms the importance of early evaluation and intervention for dysphagia prior to and during CRT or RT alone.
确定吞咽功能保留方案(SPP)对接受放化疗(CRT)或单纯放疗(RT)的头颈部鳞状细胞癌(HNSCC)患者吞咽功能的维持效果。
回顾性病例系列研究。
退伍军人事务医疗中心。
对2006年2月至2013年11月期间接受CRT或RT治疗的HNSCC患者进行研究。参与SPP的患者在癌症治疗期间进行吞咽、颌部和舌部运动。对照组在CRT期间未接受吞咽干预。使用先前描述的功能性吞咽结果量表(FOSS;0 = 无症状,5 = 完全通过非经口途径获取所有营养)对癌症治疗前及治疗结束时的吞咽困难进行量化,并进行分析以比较吞咽功能。
SPP组和对照组分别纳入了41例患者(均为男性;平均年龄66岁)和66例患者(均为男性;平均年龄61岁)。在SPP组中,治疗前和治疗后的平均FOSS评分分别为2.2和2.2,而对照组相应的评分分别为1.8和2.7,仅对照组治疗后的FOSS评分显著低于治疗前。
与对照组相比,参与SPP的患者在癌症治疗过程中吞咽功能得以保留。这证实了在CRT或单纯RT之前及期间对吞咽困难进行早期评估和干预的重要性。